Evidence map›Paper›PMID 32877400›Full record

ArticlePLoS genetics2020

Trappc9 deficiency causes parent-of-origin dependent microcephaly and obesity.

Zhengzheng S Liang, Irene Cimino, Binnaz Yalcin, Narayanan Raghupathy, Valerie E Vancollie, Ximena Ibarra-Soria, Helen V Firth, Debra Rimmington, I Sadaf Farooqi, Christopher J Lelliott and 5 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Identification ofFrontiers in veterinary science · 2022
    Article
  14. Variable allelic expression of imprinted genes at theFrontiers in cell and developmental biology · 2022
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Zhengzheng S LiangWellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom.ORCID 0000-0002-3969-4199
Irene CiminoMRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0003-1397-5408
Binnaz YalcinInstitut de Génétique et de Biologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Université de Strasbourg, France.ORCID 0000-0002-1924-6807
Narayanan RaghupathyThe Jackson Laboratory, Bar Harbor, Maine, United States of America.ORCID 0000-0002-2275-3674
Valerie E VancollieWellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom.ORCID 0000-0003-1547-1975
Ximena Ibarra-SoriaCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-9387-3841
Helen V FirthDepartment of Clinical Genetics, Addenbrooke's Hospital, Cambridge, United Kingdom.
Debra RimmingtonMRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
I Sadaf FarooqiUniversity of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, United Kingdom.ORCID 0000-0001-7609-3504
Christopher J LelliottWellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom.ORCID 0000-0001-8087-4530
Steven C MungerThe Jackson Laboratory, Bar Harbor, Maine, United States of America.ORCID 0000-0002-8458-1871
Stephen O'RahillyMRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0003-2199-4449
Anne C Ferguson-SmithDepartment of Genetics, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0003-4996-9990
Anthony P CollMRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
Darren W LoganWellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom.ORCID 0000-0003-1545-5510
Wellcome/MRC Institute of Metabolic Science · GBWellcome Sanger Institute · GBUniversity of Cambridge · GBJackson Laboratory · USAddenbrooke's Hospital · GBInserm · FR

Funding

Leveraging Natural Genetic Diversity and Systems Genetics to Elucidate the Complex Hierarchy of Gene Regulation Underlying Ground State Pluripotency, Cell Fate Decisions and Tissue HomeostasisR35GM133495 · NIGMS · JACKSON LABORATORY · PI MUNGER, STEVEN CARMEN · 2019 to 2023
$2.0M
Department of HealthMedical Research Council MC_UU_00014/1Medical Research Council MC_UU_00014/5Medical Research Council MC_UU_12012/1Medical Research Council MC_UU_12012/5Medical Research Council MR/J001597/1Medical Research Council MR/R009791/1NIGMS NIH HHS R35 GM133495Wellcome Trust 207462/Z/17/ZWellcome Trust WT095606Wellcome Trust WT098051Wellcome Trust WT206194
6 · The paper itself

Abstract

Some imprinted genes exhibit parental origin specific expression bias rather than being transcribed exclusively from one copy. The physiological relevance of this remains poorly understood. In an analysis of brain-specific allele-biased expression, we identified that Trappc9, a cellular trafficking factor, was expressed predominantly (~70%) from the maternally inherited allele. Loss-of-function mutations in human TRAPPC9 cause a rare neurodevelopmental syndrome characterized by microcephaly and obesity. By studying Trappc9 null mice we discovered that homozygous mutant mice showed a reduction in brain size, exploratory activity and social memory, as well as a marked increase in body weight. A role for Trappc9 in energy balance was further supported by increased ad libitum food intake in a child with TRAPPC9 deficiency. Strikingly, heterozygous mice lacking the maternal allele (70% reduced expression) had pathology similar to homozygous mutants, whereas mice lacking the paternal allele (30% reduction) were phenotypically normal. Taken together, we conclude that Trappc9 deficient mice recapitulate key pathological features of TRAPPC9 mutations in humans and identify a role for Trappc9 and its imprinting in controlling brain development and metabolism.

Indexed as

AnimalsChildFemaleGene Expression RegulationGene FrequencyGenomic ImprintingHeterozygoteHomozygoteHumansIntercellular Signaling Peptides and ProteinsMaleMaternal InheritanceMiceMice, Inbred C57BLMice, KnockoutMicrocephalyIntercellular Signaling Peptides and ProteinsTRAPPC9 protein, human

Identifiers

PMID32877400
PMCPMC7467316
OpenAlexW3081808386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.